Trade LeMaitre Vascular Inc - LMAT CFD

LeMaitre Vascular Company profile

About LeMaitre Vascular Inc

LeMaitre Vascular, Inc. is a medical device company. The Company provides medical devices and human tissue cryopreservation services used in the treatment of peripheral vascular disease, end-stage renal disease and cardiovascular disease. It develops, manufactures and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons and neurosurgeons. Its portfolio of devices consists of products that are used in arteries and veins outside of the heart, which includes the LeMaitre valvulotome, the XenoSure biologic patch, the Artegraft collagen vascular graft, the Pruitt F3 carotid shunt, VascuTape radiopaque tape and Syntel embolectomy catheters. Its product line includes Valvulotomes, Surgical Glue, Remote Endarterectomy Devices, Radiopaque Tape, Powered Phlebectomy, ePTFE Vascular Grafts, Polyester Vascular Grafts, Ovine Vascular Grafts, Closure Systems, Carotid Shunts, Allografts, Angioscopes and many others.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, LeMaitre Vascular Inc revenues increased 19% to $154.4M. Net income increased 27% to $26.9M. Revenues reflect United States segment increase of 25% to $93.9M, Other countries segment increase of 14% to $47.6M. Net income benefited from Foreign currency loss decrease of 65% to $116K (expense). Dividend per share increased from $0.37 to $0.43.

Equity composition

Common Stock $.01 Par, 03/11, 100M auth., 16,144,485 issd., less 639,155 shs. in Treas. @ $3.8M. Insiders control 36.71%. IPO: 10/06,5.5M shs. @ $7 per share by Goldman, Sachs & Co., CIBC Worlds Markets, Cowen & Co. and Thomas Weisel Partners LLC. Pref. Stock $.01 Par, 5M auth.,none issued.